424 related articles for article (PubMed ID: 9847290)
21. The involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthma.
Lee YC; Lee HB; Rhee YK; Song CH
Clin Exp Allergy; 2001 Oct; 31(10):1623-30. PubMed ID: 11678864
[TBL] [Abstract][Full Text] [Related]
22. Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma.
Park HS; Kim HA; Jung JW; Kim YK; Lee SK; Kim SS; Nahm DH
Clin Exp Allergy; 2003 Jan; 33(1):113-8. PubMed ID: 12534559
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
24. Metalloproteinase-9 in induced sputum correlates with the severity of the late allergen-induced asthmatic response.
Boulay ME; Prince P; Deschesnes F; Chakir J; Boulet LP
Respiration; 2004; 71(3):216-24. PubMed ID: 15133340
[TBL] [Abstract][Full Text] [Related]
25. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis.
Delacourt C; Le Bourgeois M; D'Ortho MP; Doit C; Scheinmann P; Navarro J; Harf A; Hartmann DJ; Lafuma C
Am J Respir Crit Care Med; 1995 Aug; 152(2):765-74. PubMed ID: 7633740
[TBL] [Abstract][Full Text] [Related]
26. [Airway remodeling assessed by high-resolution computed tomography in patients with asthma: relationship to biological markers in induced sputum].
Wu SM; Li CE; Cai RP; Zhang Q; Xu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Dec; 35(12):892-6. PubMed ID: 23328178
[TBL] [Abstract][Full Text] [Related]
27. The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia.
Choi KH; Lee HB; Jeong MY; Rhee YK; Chung MJ; Kwak YG; Lee YC
Chest; 2002 May; 121(5):1478-85. PubMed ID: 12006432
[TBL] [Abstract][Full Text] [Related]
28. [Implication of extracellular matrix metalloproteinases in the course of chronic inflammatory airway diseases].
Lechapt-Zalcman E; Escudier E
Morphologie; 2000 Jun; 84(265):45-9. PubMed ID: 11048298
[TBL] [Abstract][Full Text] [Related]
29. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249
[TBL] [Abstract][Full Text] [Related]
30. Increased matrix metalloproteinase-9 in the airway after allergen challenge.
Kelly EA; Busse WW; Jarjour NN
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1157-61. PubMed ID: 10988146
[TBL] [Abstract][Full Text] [Related]
31. Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma.
Barbaro MP; Spanevello A; Palladino GP; Salerno FG; Lacedonia D; Carpagnano GE
Eur J Intern Med; 2014 Jan; 25(1):92-6. PubMed ID: 24070522
[TBL] [Abstract][Full Text] [Related]
32. Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients.
Higashimoto Y; Yamagata Y; Iwata T; Okada M; Ishiguchi T; Sato H; Masuda M; Itoh H
Eur Respir J; 2005 May; 25(5):885-90. PubMed ID: 15863647
[TBL] [Abstract][Full Text] [Related]
33. MMP-7 and TIMP-1, new targets in predicting poor wound healing in apical periodontitis.
Letra A; Ghaneh G; Zhao M; Ray H; Francisconi CF; Garlet GP; Silva RM
J Endod; 2013 Sep; 39(9):1141-6. PubMed ID: 23953287
[TBL] [Abstract][Full Text] [Related]
34. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease.
Cataldo D; Munaut C; Noël A; Frankenne F; Bartsch P; Foidart JM; Louis R
Int Arch Allergy Immunol; 2000 Nov; 123(3):259-67. PubMed ID: 11112863
[TBL] [Abstract][Full Text] [Related]
35. Imbalance between matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) contributes to bladder compliance changes in rabbits with partial bladder outlet obstruction (PBOO).
Yang L; Liu R; Wang X; He D
BJU Int; 2013 Aug; 112(4):E391-7. PubMed ID: 23305285
[TBL] [Abstract][Full Text] [Related]
36. Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects.
Mautino G; Henriquet C; Jaffuel D; Bousquet J; Capony F
Am J Respir Crit Care Med; 1999 Jul; 160(1):324-30. PubMed ID: 10390419
[TBL] [Abstract][Full Text] [Related]
37. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
38. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics.
Mautino G; Oliver N; Chanez P; Bousquet J; Capony F
Am J Respir Cell Mol Biol; 1997 Nov; 17(5):583-91. PubMed ID: 9374109
[TBL] [Abstract][Full Text] [Related]
39. Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa.
Di Stefano A; Turato G; Maestrelli P; Mapp CE; Ruggieri MP; Roggeri A; Boschetto P; Fabbri LM; Saetta M
Am J Respir Crit Care Med; 1996 Feb; 153(2):629-32. PubMed ID: 8564109
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge.
Cataldo DD; Bettiol J; Noël A; Bartsch P; Foidart JM; Louis R
Chest; 2002 Nov; 122(5):1553-9. PubMed ID: 12426252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
